Health and Healthcare
24/7 Wall St. Biotech Report: Short-Selling And Splits (AMGN)(CELG)
Published:
Last Updated:
Short sellers moved out of biotech stocks in the latest period according to Biohealth Investor.
The short interest in Amgen (AMGN) dropped 22% and Calgene (CELG) fell 20%.
Alexion Pharmaceuticals (ALXN) split its shares 2-for-1 stock.
The company’s stock has done well as this was in the mid-$70’s in mid-July and shares put in a new 52-week and multi-year high this week with shares briefly trading above $95.00.
It’s Your Money, Your Future—Own It (sponsor)
Are you ahead, or behind on retirement? For families with more than $500,000 saved for retirement, finding a financial advisor who puts your interest first can be the difference, and today it’s easier than ever. SmartAsset’s free tool matches you with up to three fiduciary financial advisors who serve your area in minutes. Each advisor has been carefully vetted and must act in your best interests. Start your search now.
If you’ve saved and built a substantial nest egg for you and your family, don’t delay; get started right here and help your retirement dreams become a retirement reality.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.